Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
9 participants
OBSERVATIONAL
2017-05-19
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To analyse data on falls to see if there has been a statistically significant drop in fall rates before and after the intervention has been implemented across these groups of wards
2. To determine a random order in which the groups of wards receive the intervention as this will make it easier to distinguish cause and effect.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Falls Prevention in Acute Care Hospital
NCT01054287
Developing a Intervention to Enhance Motivation for Physical Activities Known to Reduce Fall Risk
NCT02433249
Developing a Falls Management Tool for Adults With ID-POC
NCT06392113
Clinical Experience of Maintaining Patient Safety in Hospital
NCT06738316
Accidental Falls Care Bundle
NCT03147521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
NIHR CLAHRC West Midlands were approached to conduct an independent evaluation. However, the service imperative does not permit any delay in implementation of the intervention. Although the intervention must not be delayed, it cannot be implemented simultaneously across all hospital wards; it must be rolled out incrementally. The unit of roll-out is a cluster of wards. There are nine clusters of wards:
Cluster A:
* Ward 40 - Gerontology - Age
* Ward 20 - Gerontology
* Ward 21 - Gerontology
Cluster B:
* Ward 41 - Stroke
* Ward 42 - Neurology
* Ward 43 - Neurosurgery
Cluster C:
* Ward 30 - Respiratory
* Ward 31 - Medical ward
* Ward 34 - Clinical Haemotology
* Ward 35 - Oncology
Cluster D:
* Ward 50 - Renal
* Ward 52 - Orthopaedics
* Ward 53 - Orthopaedics
Cluster E:
* Ward 10 - Cardiology
* Ward 11 - Cardiothoracic Surgery
Cluster F:
* Cedar Ward - Orthopaedics
* Hoskyn Ward
* Mulberry Ward
* Oak Ward - Rehab
Cluster G:
* Ward 32 - Head \& Neck
* Ward 33 - Surgery
* Ward 33 - Gastro
* Ward 33 - Urology
Cluster H:
* Ward 21 - Short-stay - Gen Surgery
* Ward 22 - ECU
* Ward 22 - Surgical Assessment Unit
* Ward 22A - Vascular Surgery
* Ward 23 - Gynaecology Suite
Cluster I:
* Ward 12/CDU - AMU1
* Ward 3 (AMU3)
* Ward 12 - Observation / Assessment Unit (ED)
* Ward 1
* AMU 2
The phased introduction across wards evokes the possibility of step wedge cluster RCT (Hemming, et al. BMJ. 2015; 350:h391). However, clusters A and B must proceed first, and clusters H and I must proceed last as these are wards with very short stay. Five clusters (C to G) are therefore available for randomisation. Once clusters have been randomised to a given order, there are no foreseeable reasons to change the order. Accordingly, a list of the five eligible clusters was sent to the CLAHRC WM Director on 17/01/17 and were randomised independently (by Dr Mark Slater at the Dept of Physics, University of Birmingham) using Microsoft Excel (each cluster was assigned a random number, the numbers were then sorted from smallest to largest), as below:
E - F - G - C - D.
The primary outcome is fall rates, and we hypothesise that fall rates will decrease over the intervention period. Fall rates per 1000 bed days per month range from 0 to 34.48. Fall rates will be collated monthly over a one year period to provide a median of approximately six months pre- and six months post-intervention data points. The data will be expressed as falls per 1000 OBDs and will be harvested from the routine data system. The senior nurse on duty has a statutory requirement to collect data on falls and enter them on the hospital computer system. We will record the date at which the intervention team start working with a new cluster. The rate at which the intervention will be rolled out is uncertain at this stage.
For analysis, the raw data from the system will be sent to Dr Karla Hemming at the University of Birmingham for statistical analysis, including adjustment for calendar time. Primary analysis will be restricted to the five randomised clusters, and secondary analysis will include the four non-randomised clusters. The evaluation will take account of correlation within clusters and auto-correlation over time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before intervention
Data from clusters before educational programme intervention implemented.
No interventions assigned to this group
After intervention
Data from clusters after educational programme intervention implemented
Educational programme
Educational programme for ward staff
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational programme
Educational programme for ward staff
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospitals Coventry and Warwickshire NHS Trust
OTHER
University of Warwick
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Richard Lilford
Director of the Collaborations for Leadership in Applied Health Research and Care West Midlands (CLAHRC WM)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals Coventry and Warwickshire
Coventry, Warwickshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UoW
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.